Anti-tumor agents
AssigneePoint Therapeutics, Inc.
InventorsBarbara Wallner, Glenn Miller
Life of this patent
Estimating the term…
Abstract
A method for treating subjects with abnormal cell proliferation is provided. The method involves administering to subjects in need of such treatment an effective amount of an agent of Formula I, to inhibit cell proliferation such as that associated with tumor growth and metastasis. A method for inhibiting angiogenesis in an abnormal proliferative cell mass by the administration of an agent of Formula I is also provided.
Claims37
A method for treating a subject having a condition characterized by an abnormal mammalian cell proliferation, comprising:
- administering to a subject in need of such treatment, an agent in an amount effective to inhibit the proliferation, wherein the agent is a compound of Formula I.
A method for inhibiting angiogenesis in a subject having a condition characterized by abnormal mammalian cell proliferation comprising:
- administering to a subject in need of such treatment, an agent in an amount effective to inhibit angiogenesis in an abnormal proliferative cell mass, wherein the agent is a compound of Formula I.
28 The method of claim 19, wherein the agent is administered in combination with surgery to remove an abnormal proliferative cell mass.
A pharmaceutical preparation comprising:
- an agent of Formula I,
- at least one other anti-cancer compound, and
- a pharmaceutically acceptable carrier.
A pharmaceutical preparation comprising:
- an agent of Formula I,
- at least one other anti-angiogenic compound, and
- a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.